Document ID: chunk:federal_register_of_legislation:F2020L01085:reg:9
Version: federal_register_of_legislation:F2020L01085
Segment Type: reg
Provision Reference: reg 9
Character Range: 4210–7059

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting aplastic anaemia or death from aplastic anaemia with the circumstances of a person's relevant service:
(1)          being pregnant at the time of the clinical onset of aplastic anaemia;
(2)          being treated with a drug specified in the Schedule 2 - Drugs of this Instrument within the one year before the clinical onset of aplastic anaemia;
(3)          being treated with a drug which is associated in the individual with:
(a)          the development of aplastic anaemia within six months of drug therapy; and
(b)          the improvement of aplastic anaemia within six months of discontinuing or tapering drug therapy;
(4)          taking a non-aspirin, nonsteroidal, anti-inflammatory drug on at least four days per week for a continuous period of at least four weeks, within the one year before the clinical onset of aplastic anaemia;
(5)          using 3,4-methylenedioxymethamphetamine (ecstasy) within the three months before the clinical onset of aplastic anaemia;
(6)          being exposed to benzene as specified on at least 30 days within the one year before the clinical onset of aplastic anaemia;
Note: being exposed to benzene as specified is defined in the Schedule 1 - Dictionary.
(7)          inhaling, ingesting or having cutaneous contact with a herbicide or insecticide from the specified list of herbicides and insecticides, on at least 30 days within the six months before the clinical onset of aplastic anaemia;
Note: specified list of herbicides and insecticides is defined in the Schedule 1 - Dictionary.
(8)          having acute hepatitis within the one year before the clinical onset of aplastic anaemia;
(9)          having a liver transplant within the six months before the clinical onset of aplastic anaemia;
(10)      having an autoimmune disease from the specified list of autoimmune diseases within the two years before the clinical onset of aplastic anaemia;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(11)      having a haematological malignancy from the specified list of haematological malignancies within the six months before the clinical onset of aplastic anaemia;
Note: specified list of haematological malignancies is defined in the Schedule 1 - Dictionary.
(12)      having a thymoma or thymic carcinoma before the clinical onset of aplastic anaemia;
(13)      having an infection with parvovirus B19 or acute infectious mononucleosis within the six months before the clinical onset of aplastic anaemia;
(14)      being pregnant at the time of the clinical worsening of aplastic anaemia;
(15)      inability to obtain appropriate clinical management for aplastic anaemia.